Breast cancer screening and diagnostic company BCAL Diagnostics (ASX:BDX) has been listed on the Australian Securities Exchange following an Initial Public Offering that raised $10 million from investors. …
Latest Video
Georgia Forrest
New Stories
-
Cyclopharm delivers record revenue as US emerges as growth engine
February 2, 2026 - - Australian Biotech -
Sandoz adds to vision care options with the listing of biosimilar aflibercept
February 2, 2026 - -
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - - Australian Biotech -
Genetic Signatures appoints seasoned life sciences executive as CEO
February 2, 2026 - - Australian Biotech -
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 - - Australian Biotech -
Recce Pharmaceuticals deepens US partnership to advance burn wound treatment
February 2, 2026 - - Australian Biotech -
Another potential turning point for immunotherapy access in Australia
February 1, 2026 - - Latest News